Nemysis Ltd and Faran S.A. Sign a Strategic Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac Disease DUBLIN, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Nemysis Ltd today announces a Strategic Cooperation with Faran S.A., a leading Greek pharma company, for the development and later commercialization of its...

Nemysis Ltd Announces Appointment of Antonino Santoro as Adviser for Scientific Affairs DUBLIN, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Nemysis Ltd today announces the appointment of Antonino Santoro to its Executive Team as Adviser for Scientific Affairs. Antonino Santoro is a Chemist,...

Nemysis Ltd. Appoints Dr. David S. Sanders to Its Scientific Advisory Board DUBLIN, Sept. 27, 2021 (GLOBE NEWSWIRE) -- David Sanders, MD, is a professor of Gastroenterology and a Consultant Gastroenterologist at the Royal Hallamshire Hospital & the University of...